Bausch + Lomb buys J&J’s dry eye relief drops for $107 million

(Reuters) -Bausch + Lomb said on Thursday it has acquired Johnson & Johnson (NYSE:)’s eye and contact lens drops for $106.5 million in an all-cash deal to expand its portfolio of over-the-counter eye care products.

This comes after the company struck a $1.75 billion deal with Swiss drugmaker Novartis late last month to buy several eye-care products including anti-inflammation eye drop Xiidra.